Welcome to Drug and Therapeutics Bulletin (DTB)
For 50 years, Drug and Therapeutics Bulletin (DTB) has provided rigorous and independent evaluations of, and practical advice on, individual treatments and the overall management of disease for doctors, pharmacists and other healthcare professionals.
DTB has always been wholly independent of the pharmaceutical industry, Government and regulatory authorities. DTB is also free of advertising and other forms of commercial sponsorship.
Nalmefene - time for last orders?
Evidence of clinical and cost effectiveness of nalmefene is far too weak; DTB questions how the cost of the drug can be justified in such a cash-strapped era for the NHS.
Suggest a Topic
Do you want to get involved in producing content for DTB and helping to set the standard for prescribing practice in the UK and around the world?
Read educational articles published in DTB and then test your knowledge on BMJ Learning: